Abstract 3749: Multi-Omic Characterization of Treatment-Naive Acute Myeloid Leukemia Reveals Subtype-Specific Features and Biomarkers of Drug Response
Yi Hsiao(University of Michigan), Marcin Cieślik(University of Michigan), Elie Traer(Memorial Sloan Kettering Cancer Center), Leanne E. Henry(University of Michigan), Gilbert S. Omenn(University of Michigan), Jefferey W. Tyner(Oregon Health & Science University), Fengchao Yu(University of Michigan), Camilo Posso(Pacific Northwest National Laboratory), Jennifer Kyle(Pacific Northwest National Laboratory), Tao Liu(United States Air Force), Ginny Xiaohe Li(University of Michigan), Mamie Lih(Johns Hopkins University), Yifat Geffen(Broad Institute), Yongchao Dou(Baylor College of Medicine), Sara J.C. Gosline(Pacific Northwest National Laboratory), Alexey I. Nesvizhskii(University of Michigan), Alec Chu(University of Michigan), Saravana M. Dhanasekaran(University of Michigan), Hui Zhang(Johns Hopkins University), Bing Zhang(Baylor Genetics), Lijun Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Chandan Kumar‐Sinha(Indira Gandhi Institute of Medical Sciences), Li Ding(Shenyang Agricultural University), Chenwei Wang(Baylor College of Medicine), Javier del Pino(Pacific Northwest National Laboratory), Yamei Deng(University of Michigan), Arul M. Chinnaiyan(University of Michigan)
Cited by 0
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k